title: Reimbursable drug classes and ceilings in Italy: why not only one?
authors.affiliation: CESAV, Centre for Health Economics, IRCCS Institute for Pharmacological Research 'Mario Negri', Via Camozzi, 3 c/o Villa Camozzi, 24020, Ranica, Bergamo, Italy. livio.garattini@marionegri.it.
authors.forename: Livio
authors.initials: L
authors.lastname: Garattini
authors.affiliation: CESAV, Centre for Health Economics, IRCCS Institute for Pharmacological Research 'Mario Negri', Via Camozzi, 3 c/o Villa Camozzi, 24020, Ranica, Bergamo, Italy.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Curto
authors.affiliation: CESAV, Centre for Health Economics, IRCCS Institute for Pharmacological Research 'Mario Negri', Via Camozzi, 3 c/o Villa Camozzi, 24020, Ranica, Bergamo, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Padula
mesh_terms: D061605:Administration, Intravenous; D003659:Decision Making, Organizational; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D006291:Health Policy; D006761:Hospitals; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics*; D007558:Italy; D009313:National Health Programs / Q000191:economics; D004364:Pharmaceutical Preparations / Q000145:classification* / Q000191:economics*
chemical_list: D004364:Pharmaceutical Preparations